Future Infectious Disease Nucleic Acid TestingVenture Planning Group
February 14, 2012
360 Pages - SKU: VPG6809702
More Antisense & RNAi Technology reports by Venture Planning Group
Analysis of Nucleic Acid Testing Technologies And Strategic Profiles of Leading Suppliers by Venture Planning Group
This 180-page report provides detailed analyses of current and emerging nucleic acid testing technologies, and their potential market applications, including DNA sequencing, RNA probes, detection ...
Analysis of Nucleic Acid Testing Instrumentation And Strategic Profiles of Leading Suppliers by Venture Planning Group
This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating NAT methods in order to facilitate their penetration into ...
Analysis of Emerging Nucleic Acid Testing Assays And Strategic Profiles of Leading Suppliers by Venture Planning Group
This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings ...
Analysis of the World Nucleic Acid Testing Market Sales Forecasts by Country and Strategic Profiles of Leading Suppliers by Venture Planning GroupSee all reports like this >>
This report provides a worldwide overview of the nucleic acid testing market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well ...
We can help you find what you need. Call us or write us:
Need help in your search?
Antisense & RNAi Technology Reports
- Antisense Therapeutics Limited – Product Pipeline Review – 2013
- RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2013
- MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets
- RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2012
- Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets